I
Isabelle C. Van Gelder
Researcher at University Medical Center Groningen
Publications - 351
Citations - 56632
Isabelle C. Van Gelder is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Atrial fibrillation & Heart failure. The author has an hindex of 74, co-authored 326 publications receiving 44197 citations. Previous affiliations of Isabelle C. Van Gelder include University of Groningen & University of Southern Denmark.
Papers
More filters
Journal ArticleDOI
Atrial Fibrillation During Cardiac Resynchronization Therapy
TL;DR: Uncertainty remains as to which thresholds of AF burden can lead to a reduced response to CRT and every effort should be made in trying to assess and guarantee successful biventricular pacing in patients with AF.
Journal ArticleDOI
Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm
Harry J.G.M. Crijns,Arif Elvan,Nadea Al-Windy,Ype S. Tuininga,Erik A Badings,Ismail Aksoy,Isabelle C. Van Gelder,Prashanti Madhavapeddi,A. John Camm,Peter R. Kowey,Jeremy N. Ruskin,Luiz Belardinelli +11 more
TL;DR: Administration of flecainide via oral inhalation was shown to be safe and to yield plasma concentrations of fle cainide sufficient to restore sinus rhythm in patients with recent-onset atrial fibrillation.
Journal ArticleDOI
The RACE to the EAST. In pursuit of rhythm control therapy for atrial fibrillation-a dedication to Harry Crijns.
Bruno Reissmann,Günter Breithardt,A. John Camm,Isabelle C. Van Gelder,Andreas Metzner,Paulus Kirchhof +5 more
TL;DR: The EAST-AFNET 4 trial as mentioned in this paper showed that early rhythm control therapy has demonstrated to reduce a composite of cardiovascular death, stroke, and hospitalization for worsening of atrial fibrillation or acute coronary syndrome.
Journal ArticleDOI
Resumption of anticoagulation after major bleeding decreases the risk of stroke in patients with atrial fibrillation
TL;DR: This study aimed to evaluate anticoagulation use after a major bleeding event on dabigatran or warfarin and compare outcomes between patients discontinuing antICOagulation and those restarting dabig atran or Warfarin.
Journal ArticleDOI
Initial experience with pulsed field ablation for atrial fibrillation
Federico T Magni,Bart A. Mulder,Hessel F. Groenveld,Ans C.P. Wiesfeld,Robert G. Tieleman,Moniek G.P.J. Cox,Isabelle C. Van Gelder,Tom D. J. Smilde,Eng-Shiong Tan,Michiel Rienstra,Yuri Blaauw +10 more
TL;DR: In this paper , the authors present their initial experience with a PFA catheter for pulmonary vein isolation (PVI) and describe procedural findings and peri-procedural safety of the first 100 patients.